免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Leksell Vantage 立体定向系统

K号: K171123 · 2017-09-15

决定日期2017-09-15
产品代码HAW
咨询委员会NE 请注意,您提供的文本“NE”不足以进行翻译,因为它不是一个完整的句子或描述。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Leksell Vantage Stereotactic System is the device name listed in this FDA 510(k) record. The listed applicant is Elekta Instrument AB. It received FDA 510(k) clearance on 2017-09-15 under 510(k) number K171123. The device is classified under product code HAW. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Leksell Vantage Stereotactic System?

Leksell Vantage Stereotactic System is a medical device that received FDA 510(k) clearance on 2017-09-15. The listed applicant is Elekta Instrument AB. The 510(k) number is K171123.

When did Leksell Vantage Stereotactic System receive FDA 510(k) clearance?

Leksell Vantage Stereotactic System received FDA 510(k) clearance on 2017-09-15, under 510(k) number K171123.

Who is the listed applicant for Leksell Vantage Stereotactic System?

The FDA 510(k) record lists Elekta Instrument AB as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Leksell Vantage Stereotactic System?

The FDA product code for Leksell Vantage Stereotactic System is HAW.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Elekta Instrument AB为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:HAW)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑